Nanovis completes $5.5M funding round to meet spinal implant demands: 3 details

Surface Technology

Nanovis generated $5.5 million during a funding round managed by Commenda Securities.

Here are three details:

1. The funds will go towards efforts to meet increased working capital and sales needs after seeing demands from surgeons and distributors for the nanotechnology-enhanced spinal implants.

2. Nanovis' FortiCore interbodies comprise porous, interconnected titanium scaffolds. The interbodies also feature a nanotube surface and are intermolded with a PEEK core.

3. Top investors included Elevate Ventures, 1st Source Capital Corp., Purdue's Foundry Investment Fund, Commenda Capital and Ellipsis Ventures.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers